EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence of muscarinic cholinergic receptor in dog portal vein binding of tritium labeled quinuclidinyl benzilate






Life Sciences 32(15): 1757-1764

Evidence of muscarinic cholinergic receptor in dog portal vein binding of tritium labeled quinuclidinyl benzilate

Muscarinic cholinergic receptor sites in dog portal veins were analyzed directly using [3H]quinuclidinyl benzilate (QNB) as a ligand. Specific [3H]QNB binding to crude membrane preparations from the isolated veins was saturable, reversible and of high affinity (Kd = 15.5 .+-. 2.8 pM) with a Bmax [maximum bound concentration] of 110 .+-. 14.7 f[femto]mol/mg protein. Scatchard and Hill plot analyses of the data indicated 1 class of binding sites. From kinetic analysis of the data, association and dissociation rate constants of 1.91 .times. 109 M-1 min-1 and 0.016 min-1, respectively, were calculated. Kd calculated from the equation Kd = K-1/K+1 was 8.3 pM, in good agreement with the Scatchard estimate of Kd (15.5 pM). Specific binding of [3H]QNB was displaced by muscarinic agents. Nicotinic cholinergic agents, .alpha.-bungarotoxin, nicotine and hexamethonium, were ineffective in displacing [3H]QNB binding at 10 .mu.M. These findings provide direct evidence for the existence of muscarinic cholinergic receptors in dog portal veins.


Accession: 005411587



Related references

Taniguchi, T.; Tsukahara, T.; Fujiwara, M., 1983: Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate. Muscarinic cholinergic receptor sites in dog portal veins were analyzed directly using [3H]quinuclidinyl benzilate (QNB) as a ligand. Specific [3H]QNB binding to crude membrane preparations from the isolated veins was saturable, reversible and of...

Aguilar J.S.; Salas P.J.I.; D.R.bertis E., 1982: Cholinergic muscarinic receptor in synaptosomal membranes heterogeneity of binding sites for l tritium labeled quinuclidinyl benzilate. The binding of radioactive L-quinuclidinyl benzilate (L-[3H]QNB) to muscarinic cholinergic receptor sites of synaptosomal membranes of cat cerebral cortex was studied. The experimental data were analyzed with the use of the Fortran IV program NLIN...

Luthin G.R.; Wolfe B.B., 1984: Tritium labeled pirenzepine and tritium labeled quinuclidinyl benzilate binding to brain muscarinic cholinergic receptors differences in measured receptor density are not explained by differences in receptor isomerization. Muscarinic receptor densities were measured in membranes prepared from rat cerebral cortex using [3H]pirenzepine and [3H]quinuclidinyl benzilate. Isotherms of equilibrium binding data modeled to a single apparent binding site for both ligands. [3H...

Luthin G.R.; Wolfe B.B., 1984: Comparison of tritium labeled pirenzepine and tritium labeled quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rat brain. The properties of [3H]quinuclidinylbenzilate ([3H]QNB) binding and [3H]pirenzepine ([3H]PZ) binding to various regions of rat brain were compared. [3H]PZ appeared to bind with high affinity to a single site, with a Kd value of .apprx. 15 mM in the...

Bito L.Z., 1979: Correlation between muscarinic receptor concentration measured by tritium labeled quinuclidinyl benzilate binding and in vivo cholinergic sensitivity of cat eyes. Investigative Ophthalmology & Visual Science: 189-190

Mittal C.K., 1985: Cholinergic muscarinic receptors in rat myocardium properties of tritium labeled quinuclidinyl benzilate binding sites. Colinergic muscarinic receptors in various rat tissue membrane preparations were labeled with [3H] quinuclidinyl benzilate (QNB), a selective high affinity muscarinic antagonist. Cardiac membranes exhibited specific saturable QNB binding which inc...

Hruska R.E.; Ludmer L.M.; Pert A.; Bunney W.E.Jr, 1984: Effects of lithium on tritium labeled levo quinuclidinyl benzilate binding to rat brain muscarinic cholinergic receptors. Addition of Li in vitro inhibited the binding of [3H]L-QNB [L-quinuclidinyl benzilate] to muscarinic cholinergic receptors of homogenates of tissue prepared from the striatum, cortex and hippocampus of rat brain. Chronic in vivo exposure of rats t...

Rimele T.J.; Rogers W.A.; Gaginella T.S., 1979: Characterization of muscarinic cholinergic receptors in the lower esophageal sphincter of the cat binding of tritium labeled quinuclidinyl benzilate. Binding of the potent muscarinic antagonist [3H]quinuclidinyl benzilate to characterize muscarinic receptors in the lower esophageal sphincter of the cat was studied. Specific binding of [3H]quinuclidinyl benzilate reached equilibrium in 25-30 min...

Roeske, W.R.; Venter, J.C., 1984: The differential loss of tritium labeled pirenzepine vs. tritium labeled levo quinuclidinyl benzilate binding to soluble rat brain muscarinic receptors indicates that pirenzepine binds to an allo steric state of the muscarinic receptor. [3H]Pirenzepine ([3H]PZ) and [3H](-)quinuclidinylbenzilate ([3H](-)QNB) specific binding to soluble rat brain muscarinic cholinergic receptors was assessed as a function of time subsequent to receptor solubilization. The soluble brain muscarinic r...

Rimele T.J.; O'dorisio M.S.; Gaginella T.S., 1981: Evidence for muscarinic receptors on rat colonic epithelial cells binding of tritium labeled quinuclidinyl benzilate. Physiological evidence suggests that muscarinic receptors mediate the secretory response of the intestinal mucosa to cholinergic agonists, but whether muscarinic receptors are intrinsic to intestinal epithelial cells is unknown. Binding of the mus...